ArticleCancers2021

RAS Mediates BET Inhibitor-Endued Repression of Lymphoma Migration and Prognosticates a Novel Proteomics-Based Subgroup of DLBCL through Its Negative Regulator IQGAP3.

Chih-Cheng Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.